MODERATOR

Jani Hegarty

Jani is the Founder and CEO of Health & Wellness Partners, LLC (HWP). HWP is a full-service medical communications agency with offices in New Jersey and California. Engaged in every aspect of the company, Jani is particularly involved with evaluating growth opportunities, value creation, strategic planning, management/development, client care, revenue generation, and brand growth. In addition to her attention to the client side of the business, Jani is a mentor and advocate for professional growth, ensuring that all HWP staff have access to career-building opportunities.

Jani also strives to give back to the broader community and is actively involved in many charitable organizations and causes, while taking on several leadership roles in her efforts.

PANELIST

Margaret Doyle

Margaret joined Global Medical Affairs Janssen in September 2020 and is currently the Senior Global Medical Affairs Leader for Teclistamab.

Margaret partners with internal colleagues and the external medical community to develop and support teclistamab as a safe and effective treatment option for patients with Multiple Myeloma. She also collaborates with experts in the field, leading their comprehensive publication strategy, executing medical education plans and running pre-approval access programs.

Margaret joined Janssen Ireland in 2008 as an MSL, where she was responsible for the Hematology, Solid Tumor and Immunology portfolio and moved into the Janssen EMEA regional organization in 2011, where she supported the launch of Zytiga for metastatic castration resistant prostate cancer, Imbruvica for B Cell Malignancies and our Myeloid portfolio.

Prior to joining Janssen, Margaret obtained a BSc Pharm degree at Trinity College, Dublin and her MSc in Clinical Pharmacy at Queens University, Belfast. Margaret completed the Certificate of Competence in Lymphoma through the University of Ulm in 2016 and completed Harvard Course in Immuno Oncology in 2021. She spent her career prior to Janssen in oncology-based hospital pharmacy roles and in the community setting.

PANELIST

Brooke McCausland

Brooke McCausland has worked in the pharmaceutical industry for over 10 years. She is passionate about making a positive impact in patients lives, especially those with Parkinsons as she lost her father to this disease in 2014. She spends her free time staying busy with the men in her life (two sons,, 7 and 10) and her husband (her high school sweetheart)

She started with Allergan working on the launches of Juvederm Voluma XC, KYBELLA, and Botox Cosmetic Forehead lines indication. She has worked across hcp and consumer marketing. Her experience stems across all facets of marketing, including but not limited to hcp marketing, DTC as well as medical marketing, specifically running speaker bureaus, peer to peer programs etc. She has worked across national training programs, traveling throughout the United States training HCPs on hands on injection techniques. Most recently Brooke drove the launch of ONGENTYS during the COVID pandemic which required a shift in all facets of the launch plan. She has been with Neurocrine for over four years as a marketing director.

PANELIST

Jennifer McIlvaine

Jennifer McIlvaine is Global Marketing Director, RSV, at AstraZeneca. Jen has 23 years of experience across pharma, biologics, and medical device with more than half at AstraZeneca leading marketing strategy and market access strategy.

Jen has delivered results in all stages of pharma life cycle from Phase III to growth to LOE, including multiple product launches at AZ and prior companies. In 2018, she was honored as a Top 25 DTC Marketer of the Year by DTC Perspectives. The experience Jen has spans across more than 15 disease states, but she has personal passion for pediatric cardiology, biologics, developing people, and delivering meaningful work to improving the lives of patients.

Jen earned a MBA from Villanova University and a BS in Chemical Engineering from Penn State University. She lives in NJ with her husband and boys. She enjoys teaching fitness classes in her spare time and cheering for her kids at local sporting events.

PANELIST

Kellan Schuh

Kellan Schuh has worked in the pharmaceutical industry around the Chicagoland area for over 12 years having worked for such respected companies as Actient, Crealta, and TerSera therapeutics; all lead and founded by Ed Fiorentino and backed by private equity group GTCR. In addition, Kellan has worked at Horizon Pharma and most recently Fresenius Kabi as their Senior Marketing Operations Manager in the Biosimilars division. Much of Kellan’s career has been spent working with companies and departments at their inception to build infrastructure, provide best practices across multiple areas of the business, and create new opportunities for her teams to build brand awareness by conducting speaker programs, managing partnerships with professional organizations, overseeing vendor effectiveness, all while finding ways to ensure the patient journey is at the forefront of all initiatives.

When Kellan is not multitasking at work, she is multitasking at home and building processes to ensure a cohesive family calendar of dance, golf, and baseball practices for her son and daughter.